Nymox says MAA submitted to Danish authorities currently under review

Nymox Pharmaceutical provides a current update on the Company’s ongoing projects. The Company recently submitted its application for Marketing Authorization Application to the Danish authorities. The application to the Danish authorities was accepted for review in February and is under review at this time. The Company now expects to be making a second new submission in the next 30-60 days. Further information will be provided when this milestone is reached, which is expected near-term in the 2nd quarter of this year.